antiulcer agent 1

Antiulcer Agent 1 is an orally administered derivative of 2-(3,4-dimethoxyphenyl)ethylamine.

Sofalcone (SU-88), a gastric antiulcer agent in clinical use, is known to induce the expression of Heme oxygenase-1 (HO-1) in gastric epithelium.

Activated Magnesium Silicate, a blend of magnesium oxide (MgO) and silicon dioxide (SiO2), serves multiple roles in healthcare and industrial applications, including as an antacid, antiulcer agent, deodorizer, decolorizer, and antifungal treatment [1].

Antiulcer Agent 2, a tetrapeptide comprising aspartic acid, alanine, histidine, and lysine, localizes at the N-terminal of human albumin. This compound shows promise in treating ulcers and producing active oxygen [1] [2].

Zolimidine, an imidazopyridine derivative, functions as an orally active antiulcer agent. It promotes mucus secretion in intestinal mucosal cells and enhances the intestinal wall's resistance to ulceration. Studies demonstrate its gastroprotective effect in duodenal ulcer research [1] [2].

Cinoxolone, a glycyrrhetinic acid derivative, functions as an antiulcer agent [1].